Long-term follow-up of vascular endothelial growth factor inhibitor therapy for neovascular age-related macular degeneration
Published 2013 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Long-term follow-up of vascular endothelial growth factor inhibitor therapy for neovascular age-related macular degeneration
Authors
Keywords
-
Journal
CURRENT OPINION IN OPHTHALMOLOGY
Volume 24, Issue 3, Pages 190-196
Publisher
Ovid Technologies (Wolters Kluwer Health)
Online
2013-03-23
DOI
10.1097/icu.0b013e32835fefee
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- An Outbreak of Streptococcus Endophthalmitis After Intravitreal Injection of Bevacizumab
- (2012) Roger A. Goldberg et al. AMERICAN JOURNAL OF OPHTHALMOLOGY
- Balancing risk in ophthalmic prescribing: assessing the safety of anti-VEGF therapies and the risks associated with unlicensed medicines
- (2012) Peter K. Kaiser et al. GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY
- HORIZON: An Open-Label Extension Trial of Ranibizumab for Choroidal Neovascularization Secondary to Age-Related Macular Degeneration
- (2012) Michael A. Singer et al. OPHTHALMOLOGY
- Ranibizumab and Bevacizumab for Treatment of Neovascular Age-related Macular Degeneration
- (2012) Daniel F. Martin et al. OPHTHALMOLOGY
- Intravitreal Aflibercept (VEGF Trap-Eye) in Wet Age-related Macular Degeneration
- (2012) Jeffrey S. Heier et al. OPHTHALMOLOGY
- Ranibizumab versus Bevacizumab to Treat Neovascular Age-related Macular Degeneration
- (2012) Usha Chakravarthy et al. OPHTHALMOLOGY
- The SECURE Study
- (2012) Rufino Silva et al. OPHTHALMOLOGY
- Myositis Ossificans
- (2011) Deborah A. Martin et al. NEW ENGLAND JOURNAL OF MEDICINE
- Safety and Efficacy of a Flexible Dosing Regimen of Ranibizumab in Neovascular Age-Related Macular Degeneration: The SUSTAIN Study
- (2011) Frank G. Holz et al. OPHTHALMOLOGY
- Cost Effectiveness of Treatments for Wet Age-Related Macular Degeneration
- (2011) Paul Mitchell et al. PHARMACOECONOMICS
- Systemic and Ocular Safety of Intravitreal Anti-VEGF Therapies for Ocular Neovascular Disease
- (2011) Michael Tolentino SURVEY OF OPHTHALMOLOGY
- Review of Ranibizumab Trials for Neovascular Age-Related Macular Degeneration
- (2011) Ravi D. Patel et al. Seminars in Ophthalmology
- Efficacy and Safety of Monthly versus Quarterly Ranibizumab Treatment in Neovascular Age-related Macular Degeneration: The EXCITE Study
- (2010) Ursula Schmidt-Erfurth et al. OPHTHALMOLOGY
- Ranibizumab Combined With Verteporfin Photodynamic Therapy in Neovascular Age-related Macular Degeneration (FOCUS): Year 2 Results
- (2008) Andrew N. Antoszyk et al. AMERICAN JOURNAL OF OPHTHALMOLOGY
- Ranibizumab versus Verteporfin Photodynamic Therapy for Neovascular Age-Related Macular Degeneration: Two-Year Results of the ANCHOR Study
- (2008) David M. Brown et al. OPHTHALMOLOGY
- The Natural History and Prognosis of Neovascular Age-Related Macular Degeneration
- (2007) Tien Wong et al. OPHTHALMOLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now